000 01510 a2200373 4500
005 20250511200016.0
264 0 _c19920316
008 199203s 0 0 eng d
022 _a0884-0431
024 7 _a10.1002/jbmr.5650060808
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaspaliaris, V
245 0 0 _aClodronate inhibits contraction and prevents the action of L-type calcium channel antagonists in vascular smooth muscle.
_h[electronic resource]
260 _bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
_cAug 1991
300 _a835-41 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aCalcium Channels
_xdrug effects
650 0 4 _aClodronic Acid
_xadministration & dosage
650 0 4 _aLanthanum
_xpharmacology
650 0 4 _aMale
650 0 4 _aMuscle, Smooth, Vascular
_xdrug effects
650 0 4 _aNicardipine
_xpharmacology
650 0 4 _aNorepinephrine
_xpharmacology
650 0 4 _aPotassium
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aVasoconstriction
_xdrug effects
650 0 4 _aVerapamil
_xpharmacology
700 1 _aLeaver, D D
773 0 _tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
_gvol. 6
_gno. 8
_gp. 835-41
856 4 0 _uhttps://doi.org/10.1002/jbmr.5650060808
_zAvailable from publisher's website
999 _c1671117
_d1671117